Cite
HARVARD Citation
Helou, J. et al. (n.d.). Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?. Radiotherapy and oncology. 123 (3), pp. 478-482. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Helou, J. et al. (n.d.). Stereotactic ablative radiotherapy in the treatment of low and intermediate risk prostate cancer: Is there an optimal dose?. Radiotherapy and oncology. 123 (3), pp. 478-482. [Online].